NCT01626677View on ClinicalTrials.gov

Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect

PHASE3CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Degenerative OsteoarthritisDefect of Articular Cartilage
Interventions
BIOLOGICAL

CARTISTEM

A single dose of 500㎕/㎠ of cartilage defect

PROCEDURE

Microfracture

Active control

Trial Locations (10)

400-711

Inha University Hospital, Incheon

405-760

Gachon University Gil Hospital, Incheon

110-746

Kangbuk Samsung Hospital, Seoul

133-792

Hanyang University Medical Center, Seoul

134-060

Seoul Veterans Hospital, Seoul

135-710

Samsung Medical Center, Seoul

135-720

Gangnam Severance Hospital, Seoul

138-736

Asan Medical Center, Seoul

152-703

Korea University Guro Hospital, Seoul

158-710

Ewha Womans University Mokdong Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY

lead

Medipost Co Ltd.

INDUSTRY